Replies to post #91442 on Ayala Pharmaceuticals Inc (ADXS)

[SKTrader1]

If you knew stock undervalued. Knew your R/S was just in case and have term sheets about to make a deal then I guess I wonder why you ask for the insulting R/S at all or why you don’t buy 500k worth of shares. Oh wait because your term sheets were just trying to manipulate the best possible RS price. I’m sorry for those who continue to get duped by these losers

[blueyedcatch]

I agree that getting the 180 day extension from the Nasdaq is the way to go for Adxs. If they can`t get a deal before delisting then they`re never gonna get a deal. Let them go to the OTC and take the toxic financing,,it`s better for Lts then the reverse option. I don`t care what anyone here thinks about that,,it`s my money and I need it back,,and that`s my best chance of getting whole. If Adxs can prove the science,they`ll go right back on the Nasdaq after. The stock can handle 250 million shares in the float,IMO,,so we have plenty of room to bring in capital. I`m not selling at .60 cents,if they take it up there now,,no way. I`m hoping for a Merck deal,and to be saved from all these terrible options.I never would`ve let Merck go this long without paying,,in fact I never would`ve done a deal with them if Adxs was footing the bill. They can afford to take chances to progress their pipeline,so why should a start up Bio tech pay for the Giant that wants to steal everything for nothing? Would`nt happen on my watch. Obviously no one at Adxs believes enough in the science to be able to convince the big boys to anti up and roll the dice.So frustrating investing in an incompetent Mngt team. They could`nt punch their way out of a paper bag. Just look at the partnerships Adro got on 1st gen therapies,,their Mngt team kicks our butt.